Payer PolicyActive
CG-DME-41 Ultraviolet Light Therapy Delivery Devices for Home Use
ANTHEM-CG-DME-41
Anthem
Effective: October 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses home-use ultraviolet light therapy delivery devices. Coverage: An in-home UVB device is medically necessary when prescribed to treat atopic dermatitis, psoriasis, or vitiligo after failure of topical therapy; cutaneous T-cell lymphoma (including mycosis fungoides and Sézary syndrome); pityriasis lichenoides; or pruritus due to hepatic or renal disease. All other indications for UVB devices and any home-use UVA devices are considered not medically necessary.
Coverage Criteria Preview
Key requirements from the full policy
"An in-home Ultraviolet B (UVB) light therapy delivery device is consideredmedically necessarywhen conditions A and B are met:"
Sign up to see full coverage criteria, indications, and limitations.